COVID-19 - ImmPort

Image CDC Coronavirus Disease 2019 – COVID 19, Alissa Eckert

Coronavirus Disease 19

Powered by ImmPort

The COVID-19 pandemic is growing exponentially. ImmPort presents an opportunity to leverage legacy studies on infectious diseases, including Influenza (over 100 studies) and other respiratory-like illnesses from diverse cohorts (e.g. age, race, gender) sourced from NIAID-sponsored programs and beyond. If you are interested in sharing your COVID research data through ImmPort please contact ImmPort_COVID19. The ImmPort team’s curation staff can provide assistance and guidance for data curation, loading and sharing.

Related viral infectious disease and respiratory disease studies:

Disease type	Assays
COVID-19 studies	ELISA
Influenza studies	ELISA, ELISPOT, Flow Cytometry, HAI
Respiratory-like illness studies	Flow cytometry, CyToF, RNA-seq, Transcription Profiling by Array
Viral infectious disease studies	ELISA, ELISPOT, Flow cytometry, CyToF, HLA-Typing, RNA-seq, Transcription Profiling by Array
COVID-19 new studies	ELISA, ELISPOT, Flow cytometry, CyToF, HLA-Typing, RNA-seq, Transcription Profiling by Array

Additional ImmPort Resources to facilitate your research:

10k Immunome

The 10,000 Immunomes Project is a reference dataset for human immunology, derived from over 10,000 control subjects in the NIAID ImmPort Database.

ImmPort API's

Download ImmPort data: Application Program Interface to query the shared data and download result files.